“…Having solved the shikimic acid availability concerns over the years by developing more efficient extraction and purification processes or alternatively by fermentation using genetically engineered E.coli bacteria, [ 25 , [28] , [29] , [30] ] the use of hazardous azide chemistry needs more attention. The application of continuous flow technology in Tamiflu synthesis proved to be a potential enabling tool for safe handling of the hazardous azide chemistry as well as improving efficiency [ 32 , 53 , 92 ] Continuous flow synthesis has attracted considerable attention in synthetic chemistry and pharmaceutical industry in the last decade owing to its well-documented advantages, [ [55] , [56] , [57] , [58] , [59] , 65 , 67 , 79 , [96] , [97] , [98] , [99] , [100] ] resulting in numerous pharmaceutical drugs approaches being redesigned into continuous flow synthesis [ 56 , 58 , [60] , [61] , [62] , [63] , [64] , [65] , 106 ] In this light, we envisage that Tamiflu synthesis can hugely benefit from continuous flow technology application to afford truly efficient synthetic procedures. Furthermore, the promising Tamiflu synthetic approaches which were previously ruled out for large scale synthesis in batch based on either safety concerns or poor efficiency can be reconsidered in flow.…”